From: Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
Characteristics | Definition | References |
---|---|---|
Demographic | 1) Elderly | [12] |
- Older adults above 64 years old | ||
Co-morbidities | 1) Cardiovascular accident (CVA) | |
- Refers to stroke, transient ischemic attack and hemorrhagic stroke, ischemic heart disease (IHD) | ||
2) Liver impairment | ||
- Refers to chronic hepatitis, liver cirrhosis, fatty liver, elevation of liver enzyme such as alanine transaminase (ALT) and aspartate transaminase (AST) of above 3 times upper limit of normal level | ||
3) Renal impairment | ||
- Creatinine clearance of <60 ml/min or as stated in medical records. | ||
Microvascular complications | 1) Retinopathy | [1] |
- Refers to funduscopic deterioration or as stated in medical records. | ||
2) Neuropathy | ||
- For sensory, included history of foot lesions; for autonomic, included sexual dysfunction and gastroparesis or as stated in medical records. | ||
Metabolic control | 1) Glycemic control | |
- Good glycemic control refers to achieving targeted level of A1C <6.5%. | ||
2) Lipid control | ||
- Good lipid control refers to achieving all lipid fractions targeted level in which LDL-C <2.6 mmol/L, TG <1.7 mmol/L and HDL-C >1.0 mmol/L. | ||
- Poor lipid control refers to those patients unable to achieve one of the lipid fractions within targeted range. | ||
Drug therapy | 1) Polypharmacy | [17] |
- Six or more chronic medications for duration of at least one month. |